Literature DB >> 12970292

Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.

Else H Johanson1, Per-Anders Jansson, Lars Lönn, Yuji Matsuzawa, Tohru Funahashi, Marja-Riitta Taskinen, Ulf Smith, Mette Axelsen.   

Abstract

To explore the mechanisms for the insulin resistance associated with a family history of type 2 diabetes, we studied 16 healthy men with at least two first-degree relatives with type 2 diabetes and 16 control subjects without known heredity. They were pair-wise matched for age, body mass index, and fasting triglycerides and underwent an oral glucose tolerance test, iv glucose infusion to measure the early insulin secretion, euglycemic hyperinsulinemic clamp, computed tomography scan, 7-d food record, and a cardiopulmonary exercise test to measure peak oxygen uptake. Insulin sensitivity index was 30% lower (P = 0.02) in relatives, compared with controls, but fasting and 2-h blood glucose and first-phase insulin secretion were similar. There were no differences in mean fasting free fatty acid levels, amount of sc or visceral adipose tissue, or fat accumulation in the liver. Dietary intake and peak oxygen uptake were also similar. However, multiple regression analysis of both groups showed that fat in the liver and physical capacity were, like known heredity for type 2 diabetes, independent predictors of insulin sensitivity. Thus, lipid accumulation in the liver and physical capacity are related to insulin sensitivity, but neither of these factors nor the amount and distribution of the body fat can explain the insulin resistance associated with a family history for type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970292     DOI: 10.1210/jc.2002-021961

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

2.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Authors:  Miriam A Bredella; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Danielle J Brick; Anu V Gerweck; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

3.  Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.

Authors:  J-P Baillargeon; A C Carpentier
Journal:  Diabetologia       Date:  2007-09-27       Impact factor: 10.122

4.  Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome.

Authors:  P Anthanont; P Ramos; M D Jensen; K C Hames
Journal:  Int J Obes (Lond)       Date:  2017-07-24       Impact factor: 5.095

5.  Circulating Monocyte and Lymphocyte Populations in Healthy First-Degree Relatives of Type 2 Diabetic Patients at Fasting and during Short-Term Hyperinsulinemia.

Authors:  Michaela Šiklová; Eva Krauzová; Barbora Svobodová; Jana Kračmerová; Marek Štěpán; Michal Koc; Vladimír Štich; Lenka Rossmeislová
Journal:  Mediators Inflamm       Date:  2019-03-11       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.